Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. De plus, nous expédions Lipoprotein Lipase Kits (69) et Lipoprotein Lipase Protéines (15) et beaucoup plus de produits pour cette protéine.
Showing 10 out of 140 products:
Cat (Feline) Monoclonal Lipoprotein Lipase Primary Antibody pour ELISA, FACS - ABIN1042621
Peterson, Ayyobi, Ma, Henderson, Reina, Deeb, Santamarina-Fojo, Hayden, Brunzell: Structural and functional consequences of missense mutations in exon 5 of the lipoprotein lipase gene. dans Journal of lipid research 2002
Show all 4 Pubmed References
Human Monoclonal Lipoprotein Lipase Primary Antibody pour ELISA, WB - ABIN969262
Berk, Johnson, Lee, Zhang, Boozer, Pi-Sunyer, Fried, Albu: Higher post-absorptive skeletal muscle LPL activity in African American vs. non-Hispanic White pre-menopausal women. dans Obesity (Silver Spring, Md.) 2008
Show all 2 Pubmed References
Cow (Bovine) Polyclonal Lipoprotein Lipase Primary Antibody pour WB - ABIN3043618
Yu, Dai, Chen, Zang, Deng, Liu, Ying: Hypolipidemic and antioxidant activities of polysaccharides from Rosae Laevigatae Fructus in rats. dans Carbohydrate polymers 2013
Show all 2 Pubmed References
Human Polyclonal Lipoprotein Lipase Primary Antibody pour WB - ABIN4331137
Zhang, Cui, Wang, Shang, Qi, Xue, Zhao, Deng, Xie: PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. dans Cytokine 2015
Chicken Monoclonal Lipoprotein Lipase Primary Antibody pour IP, ELISA - ABIN2475335
Peterson, Fujimoto, Brunzell: Human lipoprotein lipase: relationship of activity, heparin affinity, and conformation as studied with monoclonal antibodies. dans Journal of lipid research 1992
Show all 3 Pubmed References
Chicken Monoclonal Lipoprotein Lipase Primary Antibody pour Func, IP - ABIN2475336
Chang, Reich, Brunzell, Will: Detailed characterization of the binding site of the lipoprotein lipase-specific monoclonal antibody 5D2. dans Journal of lipid research 1999
Show all 3 Pubmed References
Chicken Monoclonal Lipoprotein Lipase Primary Antibody pour IP, ELISA - ABIN2475333
Hussain, Obunike, Shaheen, Hussain, Shelness, Goldberg: High affinity binding between lipoprotein lipase and lipoproteins involves multiple ionic and hydrophobic interactions, does not require enzyme activity, and is modulated by glycosaminoglycans. dans The Journal of biological chemistry 2000
Show all 3 Pubmed References
ANGPTL8 has a functional LPL (Montrer LCP1 Anticorps) inhibitory motif, but only inhibits LPL (Montrer LCP1 Anticorps) and increases plasma TG levels in mice in the presence of ANGPTL3 (Montrer ANGPTL3 Anticorps)
The expression of COBLL1, LPL, and ZAP70 corresponded to patient prognosis and to IGHV mutational status, although not absolutely. When we combined all three markers together and performed the ROC analysis, AUC increased compared to the AUC of individual gene expression.
heterozygous N291S mutation in the lipoprotein lipase gene impairs whole-body insulin (Montrer INS Anticorps) sensitivity and affects a distinct set of plasma metabolites in humans
LPL (Montrer LCP1 Anticorps) is important for the maturation of small discoidal HDL (Montrer HSD11B1 Anticorps) particles into large spherical HDL (Montrer HSD11B1 Anticorps) particles, while HL is important for HDL (Montrer HSD11B1 Anticorps) remodeling of very large HDL (Montrer HSD11B1 Anticorps) particles into intermediate-size HDL (Montrer HSD11B1 Anticorps) particles, as shown in lipoprotein lipase and hepatic lipase (Montrer LIPC Anticorps) deficiency
The authors now show: (1) that ANGPTL4 (Montrer ANGPTL4 Anticorps) inactivates LPL (Montrer LCP1 Anticorps) by catalyzing the unfolding of its hydrolase domain; (2) that binding to GPIHBP1 (Montrer GPIHBP1 Anticorps) renders LPL (Montrer LCP1 Anticorps) largely refractory to this inhibition; and (3) that both the LU domain and the intrinsically disordered acidic domain of GPIHBP1 (Montrer GPIHBP1 Anticorps) are required for this protective effect.
Carrier status for the two common LPL (Montrer LCP1 Anticorps) variants: 447Ter (low TG/high HDL (Montrer HSD11B1 Anticorps)-C) and 291Ser (high TG/low HDL (Montrer HSD11B1 Anticorps)-C) was determined. Compared with the reference variant, the prevalence of metabolic syndrome was lower in carriers of the 447Ter variant (11.2% vs. 17.9%, P < 0.001) but with no difference in carriers of the 291Ser variant (18.4% vs. 16.5%, P = 0.59).
A rare variant in APOC3 (Montrer APOC3 Anticorps)(rs138326449) has been associated with triglyceride, very low-density lipoprotein, and high-density lipoprotein levels, as well as risk of coronary heart disease. Effects are unlikely to be solely predictable by the action of APOC3 (Montrer APOC3 Anticorps) through LPL (Montrer LCP1 Anticorps).
LPL (Montrer LCP1 Anticorps) gene polymorphisms are not genetic markers for the development of stroke in the Colombian sample used.
Acute hypoxia strongly inhibits lipoprotein lipase activity in differentiated human preadipocytes.
novel mutations cause type 1 hyperlipoproteinemia by inducing a loss or reduction in LPL (Montrer LCP1 Anticorps) secretion accompanied by a loss of LPL (Montrer LCP1 Anticorps) enzymatic activity
isothermal titration calorimetry (ITC) can be used for quantitative measurements of LPL activity and interactions under in vivo-like conditions, for comparisons of the properties of plasma samples from patients and control subjects as substrates for LPL, as well as for testing of drug candidates developed with the aim to affect the LPL system.
miR (Montrer MYLIP Anticorps)-29b targets LPL and TDG (Montrer TDG Anticorps) genes and regulates apoptosis and triglyceride production in mammary epithelial cells.
apoC-I (Montrer APOC1 Anticorps) and apoC-III (Montrer APOC3 Anticorps) inhibit lipolysis by displacing LPL from lipid emulsion particles. We also propose a role for these apolipoproteins in the irreversible inactivation of LPL by factors such as angptl4 (Montrer ANGPTL4 Anticorps).
ANGPTL4 (Montrer ANGPTL4 Anticorps) is more accurately described as a reversible, noncompetitive inhibitor of LPL.
Our findings confirmed that three novel SNPs we identified in the LPL gene can affect fatty acid composition and carcass traits. Therefore, selection for AA and GA genotypes should be recommended to genetically improve beef quality and flavor.
Single nucleotide polymorphisms of the LPL gene might be useful genetic markers for growth traits in the bovine reproduction and breeding.
Results describe the functional role of the secondary structure in the lipoprotein lipase-binding portion of apolipoprotein CII (Montrer APOC2 Anticorps).
regions that are responsive to activation by apoC-II (Montrer APOC2 Anticorps)
domain (192-238) is absolutely necessary for apolipoprotein AV (Montrer APOA5 Anticorps) in lipid binding and lipoprotein lipase activation
The data suggests that ANGPTL3 (Montrer ANGPTL3 Anticorps) is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice.
Using in vitro ketosis model by glucose starvation, studied inhibition of ketosis by momilactone B. Found momilactone B could regulate the angiopoietin-like-3 (ANGPTL3 (Montrer ANGPTL3 Anticorps))-lipoprotein lipase (LPL)pathway, and suppressed the expression of HMGCS2 (Montrer HMGCS2 Anticorps) through the increased expression of STAT5b (Montrer STAT5B Anticorps).
physiological changes in adipose tissue ANGPTL4 (Montrer ANGPTL4 Anticorps) expression during fasting and cold resulted in inverse changes in the amount of mature-glycosylated LPL in wild-type mice, but not Angptl4 (Montrer ANGPTL4 Anticorps)(-/-) mice. We conclude that ANGPTL4 (Montrer ANGPTL4 Anticorps) promotes loss of intracellular LPL by stimulating LPL degradation after LPL processing in the endoplasmic reticulum (ER).
LPL moved quickly from heparan sulfate proteoglycans (HSPGs) on adipocytes to GPIHBP1 (Montrer GPIHBP1 Anticorps)-coated beads, thereby depleting LPL stores on the surface of adipocytes. We conclude that HSPG (Montrer SDC2 Anticorps)-bound LPL in the interstitial spaces of tissues is mobile, allowing the LPL to move to GPIHBP1 (Montrer GPIHBP1 Anticorps) on endothelial cells
our study reveals that hepatic LPL is involved in the regulation of plasma LPL activity and lipid homeostasis.
The induction of LPL activity by fasting in core transgenic mice activated PPARalpha (Montrer PPARA Anticorps) downstream target genes that are involved in fatty acid beta-oxidation.
This study shows that TNF-alpha (Montrer TNF Anticorps), by a Foxo1 (Montrer FOXO1 Anticorps) dependent pathway, increases the transcription of ANGPTL4 (Montrer ANGPTL4 Anticorps) which is secreted by the cells and causes inactivation of LPL.
Our findings suggest that neuronal LPL is involved in the regulation of body weight and composition in response to either the change in quantity (HF feeding) or quality (n-3 PUFA-enriched) of dietary fat
An LPL structural model suggests that the LPL S447X truncation exposes residues implicated in LPL binding to lipoprotein binding uptake receptors, such as GPIHBP1 (Montrer GPIHBP1 Anticorps).
feeding induces lipasin, activating the lipasin-Angptl3 (Montrer ANGPTL3 Anticorps) pathway, which inhibits LPL in cardiac and skeletal muscles to direct circulating TAG to WAT for storage
LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism.
, O 1-4-5
, adipose lipoprotein lipase
, triacylglycerol lipase